Sickle Cell Disease Treatment Market is geared to grow at a CAGR of 12% from 2023 to 2032 | insightS

The market for treatments for sickle cell disease was valued at US$ 900 million in 2021 and is projected to grow at a CAGR of 12% through 2032.Currently, it appears that between 22 and 27 million people worldwide have sickle cell disease, and each year, 317,000 additional babies are born with the condition. The need...

Related Keywords

Mexico ,Germany ,Australia ,Nigeria ,United States ,India ,Ghana ,Brazil ,South Africa ,Saudi Arabia ,Canada ,France ,America ,Asia Pacific ,Bristol Myers Squibb ,Glycomimetics Inc ,Pfizer Inc ,Bluebird Bio Inc ,Emmaus Life Sciences Inc ,Global Blood Therapeutics Inc ,Global Sickle Cell Disease Treatment Market ,Bluebird Bio ,Global Blood Therapeutics ,Emmaus Life Sciences ,Sickle Cell ,Global Sickle Cell Disease Treatment ,Sickle Cell Disease Treatment ,Middle Eastern ,South Asian ,Electric Dental Handpiece Market ,Digital Pathology Market ,